Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA with Propofol or Dexmedetomidine vs Sevoflurane in Pediatric BMA
NCT05636566Phase 3Completed
- Sponsor
- Alexandria University
- Start
- Feb 2022
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dexmedetomidine in pediatric cancer (3 arms), sponsored by Alexandria University. Primary endpoint: Postoperative Sedation Score. Started Feb 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
pediatric cancer
Beyond the preview
Go deeper on NCT05636566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05636566.